Daiwa Securities Group
ATRA icon

Daiwa Securities Group’s Atara Biotherapeutics ATRA Stock Holding History

Daiwa Securities Group’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12
Closed – – 1330
2023
Q3 		$0 Hold
12
– – ﹤0.01% 1292
2023
Q2 		$0 Sell
12
-615
-98% -$34.8K ﹤0.01% 1324
2023
Q1 		$45K Buy
627
+121
+24% +$11.7K ﹤0.01% 1052
2022
Q4 		$41K Buy
506
+56
+12% +$5.84K ﹤0.01% 1056
2022
Q3 		$43K Sell
450
-119
-21% -$13.4K ﹤0.01% 1072
2022
Q2 		$111K Buy
569
+557
+4,642% +$90.9K ﹤0.01% 1012
2022
Q1 		$3K Hold
12
– – ﹤0.01% 1209
2021
Q4 		$5K Hold
12
– – ﹤0.01% 1191
2021
Q3 		$5K Buy
12
+6
+100% +$2.15K ﹤0.01% 1174
2021
Q2 		$2K Hold
6
– – ﹤0.01% 1135
2021
Q1 		$2K Hold
6
– – ﹤0.01% 1136
2020
Q4 		$3K Sell
6
-10
-63% -$4.62K ﹤0.01% 1079
2020
Q3 		$5K Buy
16
+4
+33% +$1.36K ﹤0.01% 1088
2020
Q2 		$3K Hold
12
– – ﹤0.01% 1136
2020
Q1 		$3K Hold
12
– – ﹤0.01% 1133
2019
Q4 		$5K Sell
12
-2
-14% -$690 ﹤0.01% 1104
2019
Q3 		$5K Buy
14
+2
+17% +$746 ﹤0.01% 1073
2019
Q2 		$6K Hold
12
– – ﹤0.01% 1081
2019
Q1 		$12K Buy
12
+4
+50% +$3.72K ﹤0.01% 1022
2018
Q4 		$7K Hold
8
– – ﹤0.01% 1021
2018
Q3 		$9K Hold
8
– – ﹤0.01% 1045
2018
Q2 		$8K Hold
8
– – ﹤0.01% 1064
2018
Q1 		$8K Buy
+8
New +$7.29K ﹤0.01% 1044

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Daiwa Securities Group's ATRA Position: Q4 2023 in Review

Daiwa Securities Group sold out of Atara Biotherapeutics (ATRA) in Q4 2023, closing a stake of 12 shares.

Daiwa Securities Group first reported a position in ATRA in Q1 2018 and held it in 23 quarters. The position peaked at $111K in Q2 2022. 90 funds tracked by Wall St. Rank hold ATRA as of Q4 2023.

  • Daiwa Securities Group reported no remaining Atara Biotherapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 12 Atara Biotherapeutics shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Atara Biotherapeutics in Q1 2018 and held it in 23 quarters.
  • Daiwa Securities Group's Atara Biotherapeutics position peaked at $111K in Q2 2022.
  • 90 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.